Johannes M. Hennings

Johannes M. Hennings

Auto-generated profile, based on publicly available information

Johannes M. Hennings

Max Planck Institute of Psychiatry, Munich, Germany

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
MIMarcus Ising
Marcus Ising
SLSusanne Lucae
Susanne Lucae
EBElisabeth B. Binder
Elisabeth B. Binder
TBThomas Bettecken
Thomas Bettecken
MUManfred Uhr
Manfred Uhr
BMBertram Müller-Myhsok
Bertram Müller-Myhsok
Antidepressant agents are indispensable in treating severe depression. Since their discovery in the 1950s, adverse effect profiles of these drugs have been improved, whereas clinical efficacy is still unsatisfactory because 1 in 3 patients does not fully recover from depression, even after several treatment trials.1,2 Genetic factors contribute to the general variability in drug response3,4 and, according to family studies,5-7 this is the case for antidepressant agents, which suggests that the individual genetic profile may provide guidance in medication selection.8 Up to now, pharmacogenetic studies have focused on candidate genes implicated in the mechanisms of antidepressant drug action or in the pharmacokinetics of such drugs. For example, an insertion-deletion polymorphism in the promoter region of the serotonin transporter gene (SLC6A4) seems to predict response to selective serotonin reuptake inhibitors,9 potentially mediated by differences in selective serotonin reuptake inhibitor tolerability,10 and a variation in the ABCB1 gene coding for a P-glycoprotein that determines brain tissue penetration of many antidepressant drugs may predict clinical outcome in patients treated with substrates of this blood-brain barrier regulation molecule.11 Several studies reported that variants of a gene coding for FKBP5,12-14 a co-chaperone involved in stress hormone signaling, and variants for 5HT2A15 are predictive of treatment response but do not effectively guide treatment selection. Further associations have been reported for the glutamatergic receptor gene GRIK4,16 the enzymatic gene PDER11A,17 inflammation-related genes (CD3E, PRKCH, PSMD9, and STAT3),18 and UCN318 expressing a ligand of the CRF2 receptor.

1 April 2011 in Neuron
Verified
Journal Article
Closed access
MKMartin A. Kohli
Martin A. Kohli
SLSusanne Lucae
Susanne Lucae
PSPhilipp G. Saemann
Philipp G. Saemann
MSMathias Schmidt
Mathias Schmidt
Ayse DemirkanAyse Demirkan
Ayse Demirkan
EBElisabeth B. Binder
Elisabeth B. Binder

18 November 2009 in Neuropsychopharmacology
Verified
Journal Article
Closed access
SHSonja Horstmann
Sonja Horstmann
SLSusanne Lucae
Susanne Lucae
AMAndreas Menke
Andreas Menke
JHJohannes M Hennings
Johannes M Hennings
MIMarcus Ising
Marcus Ising
EBElisabeth B Binder
Elisabeth B Binder

1 January 2009 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
JHJohannes M. Hennings
Johannes M. Hennings
TOToshimi Owashi
Toshimi Owashi
EBElisabeth B. Binder
Elisabeth B. Binder
SHSonja Horstmann
Sonja Horstmann
AMAndreas Menke
Andreas Menke
SLSusanne Lucae
Susanne Lucae

1 April 2010 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
MKMartin A. Kohli
Martin A. Kohli
DSDaria Salyakina
Daria Salyakina
APAndrea Pfennig
Andrea Pfennig
SLSusanne Lucae
Susanne Lucae
SHSonja Horstmann
Sonja Horstmann
EBElisabeth B. Binder
Elisabeth B. Binder
Suicide represents a major public health problem. Each year, an estimated 10 to 20 million suicides are attempted and 1 million suicides are completed worldwide.1 The overall lifetime prevalence of suicide attempts (SAs) ranges between 3% and 5%, with similar numbers across different populations.2,3 Patients with psychiatric disorders are at higher risk for SA, with patients with mood disorder showing the highest relative risk for lifetime SA (odds ratio [OR] = 7.8-29.9), followed by patients with other psychiatric diagnoses (OR = 2.1-6.5).3 This increased risk is also reflected by reported estimates for lifetime prevalence of completed suicide being higher in patients with mood disorder than in the general population (2%-4% vs 0.5%, respectively).4 Twin and family studies suggest that suicide and SA are heritable traits5,6 and likely part of the same phenotype, with completed suicide and SA clustering in the same families.7-11 The genetic risk factors for suicide appear to be independent from the underlying psychiatric disorder.7,9,12-14

30 September 2020 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
LHLara Henco
Lara Henco
ADAndreea Diaconescu
Andreea Diaconescu
JLJuha M. Lahnakoski
Juha M. Lahnakoski
MBMarie-Luise Brandi
Marie-Luise Brandi
SHSophia Hörmann
Sophia Hörmann
CMChristoph Mathys
Christoph Mathys
Psychiatric disorders are ubiquitously characterized by debilitating social impairments. These difficulties are thought to emerge from aberrant social inference. In order to elucidate the underlying computational mechanisms, patients diagnosed with major depressive disorder (N = 29), schizophrenia (N = 31), and borderline personality disorder (N = 31) as well as healthy controls (N = 34) performed a probabilistic reward learning task in which participants could learn from social and nonsocial information. Patients with schizophrenia and borderline personality disorder performed more poorly on the task than healthy controls and patients with major depressive disorder. Broken down by domain, borderline personality disorder patients performed better in the social compared to the non-social domain. In contrast, controls and MDD patients showed the opposite pattern and SCZ patients showed no difference between domains. In effect, borderline personality disorder patients gave up a possible overall performance advantage by concentrating their learning in the social at the expense of the non-social domain. We used computational modeling to assess learning and decision-making parameters estimated for each participant from their behavior. This enabled additional insights into the underlying learning and decision-making mechanisms. Patients with borderline personality disorder showed slower learning from social and non-social information and an exaggerated sensitivity to changes in environmental volatility, both in the non-social and the social domain, but more so in the latter. Regarding decision-making the modeling revealed that compared to controls and major depression patients, patients with borderline personality disorder and schizophrenia showed a stronger reliance on social relative to non-social information when making choices. Depressed patients did not differ significantly from controls in this respect. Overall, our results are consistent with the notion of a general interpersonal hypersensitivity in borderline personality disorder and schizophrenia based on a shared computational mechanism characterized by an over-reliance on beliefs about others in making decisions and by an exaggerated need to make sense of others during learning specifically in borderline personality disorder. People suffering from psychiatric disorders frequently experience difficulties in social interaction, such as an impaired ability to use social signals to build representations of others and use these to guide behavior. Compuational models of learning and decision-making enable the characterization of individual patterns in learning and decision-making mechanisms that may be disorder-specific or disorder-general. We employed this approach to investigate the behavior of healthy participants and patients diagnosed with depression, schizophrenia, and borderline personality disorder while they performed a probabilistic reward learning task which included a social component. Patients with schizophrenia and borderline personality disorder performed more poorly on the task than controls and depressed patients. In addition, patients with BPD concentrated their learning efforts more on the social compared to the non-social information. Computational modeling additionally revealed that borderline personality disorder patients showed a reduced flexibility in the weighting of newly obtained social and non-social information when learning about their predictive values. Instead, we found exagerrated learning of the volatility of social and non-social information. Additionally, we found a pattern shared between patients with borderline personality disorder and schizophrenia who both showed an over-reliance on predictions about social information during decision-making. Our modeling, therefore, provides a computational account of the exaggerated need to make sense of and rely on one’s interpretation of others’ behavior, which is prominent in both disorders.